Pharmabiz
 

Making of a world leader in life sciences tools industry

Thursday, December 13, 2007, 08:00 Hrs  [IST]

Millipore Corporation, a life science leader providing technologies, tools and services for the bioscience research and biopharmaceutical manufacturing industry, acquired Serologicals, which is perceived by the company as one of the most strategic initiatives for the benefit of life science researchers. The company acquired Serologicals in its entirety, which included multiple companies that develop and sell a variety of products. With this, Serologicals' brands from Chemicon, Upstate and Linco now become available to Indian researchers through Millipore India. Chemicon has a broad range of research products including speciality antibodies, proteins, cell lines, media and other reagents and tools for customers focused on the areas of neuroscience, infectious diseases, oncology and stem cell research. The company also supplies monoclonal antibodies, conjugates and biologically-based detection kits for use in diagnostic laboratories. On the other hand, Upstate provide a wide range of research products and services, including speciality reagents, monoclonal antibodies, proteins and kits utilised in cell signalling research and compound screening against kinases, ion channels and GPCR's to increase the efficiency of compound selection and assist in detecting potentially toxic side effects from new therapeutic compounds. Linco developed immunoassay kits for detection and identification of proteins to facilitate research in metabolic diseases such as diabetes, obesity and cardiovascular disease. The acquisition of Serologicals is of importance to Indian researchers engaged in stem cell research, infectious diseases, immunodetection, drug discovery, cytokines and growth factors, cell signaling, cell surface markers, protein expression studies, cardiovascular and endocrinal disorders, apoptosis and cancer biology, nervous system development and differentiation, liquid phase protein arrays/ multiplex arrays, matrix biology, biomarkers, chromatin and histone biology. The availability of profiling assay services like the CardiacProfiler, GPCRProfiler, IC50Profiler, KinaseProfiler, PathwayProfiler and PIProfiler would expedite research. Uther, Millipore's enzyme-labelled secondary antibodies, including the hyper-HRP labelled antibody, offer unparalleled sensitivity and permanence in immunohistochemistry applications. The enzyme conjugated antibodies, depending on application, may produce either a protein luminescence or colour the proteins to be visible on the membrane. Biotin conjugation provides high levels of signal amplification with minimal cost. Combining biotinylated secondaries with a matching line of conjugated streptavidin partners, signals can be multiplied quickly, enhancing their sensitivity in all applications. Fluorescently labelled antibodies are available conjugated to a variety of fluorophores spanning the entire visible and UV spectrum. Millipore can now offer adenoviral shRNA expression vector reagents targeting the human druggable genome in addition to the solutions for RNAi experimentation. A neurofilament ELISA kit is available for detecting the extent of spinal cord and brain injuries and finding axonal degeneration in neurological diseases, such as ALS and multiple sclerosis. The kit measures upregulation of pNF-H in a variety of damage, intoxication and disease states. This assay functions on all mammalian species tested to date, including rat, mouse, rabbit, cat, pig, cow and human.

 
[Close]